Literature DB >> 12498341

EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics.

Verner J Knott1, Alain LaBelle, Barry Jones, Colleen Mahoney.   

Abstract

Electroencephalographic (EEG) coherence is an index of brain regional coupling that has been found to be abnormal in people with schizophrenia but has not been systematically examined in response to neuroleptics. EEG coherence in slow (delta and theta) frequencies was assessed in 17 treatment-resistant people with schizophrenia at baseline, 2 hr after their first oral dose (25 mg) and after 6 weeks of clozapine treatment. Compared with EEG norms, participants exhibited significant interhemispheric and intrahemispheric coherence abnormalities prior to treatment. Both acute and chronic treatments altered coherence but differed with respect to their relationship to symptom reduction and their ability to normalize or augment pretreatment abnormalities. Findings are discussed in relation to "disconnection" theories of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498341     DOI: 10.1037//1064-1297.10.4.435

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  3 in total

Review 1.  Factors associated with response to clozapine in schizophrenia: a review.

Authors:  Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Haruo Kashima
Journal:  Psychopharmacol Bull       Date:  2011

Review 2.  Brain-imaging studies of treatment-resistant schizophrenia: a systematic review.

Authors:  Elias Mouchlianitis; Robert McCutcheon; Oliver D Howes
Journal:  Lancet Psychiatry       Date:  2016-03-04       Impact factor: 27.083

3.  Functionally aberrant electrophysiological cortical connectivities in first episode medication-naive schizophrenics from three psychiatry centers.

Authors:  Dietrich Lehmann; Pascal L Faber; Roberto D Pascual-Marqui; Patricia Milz; Werner M Herrmann; Martha Koukkou; Naomi Saito; Georg Winterer; Kieko Kochi
Journal:  Front Hum Neurosci       Date:  2014-08-20       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.